Montgomery, NJ, United States of America

Kai Ma

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Inventor Kai Ma

Introduction

Kai Ma is an accomplished inventor based in Montgomery, NJ (US). He has made significant contributions to the field of oncology through his innovative work in nanoparticle drug conjugates. With a total of 2 patents to his name, his research focuses on targeted cancer therapies.

Latest Patents

Kai Ma's latest patents include "Folate receptor targeted nanoparticle drug conjugates and uses thereof." This patent discloses nanoparticle drug conjugates (NDC) that comprise ultrasmall nanoparticles, folate receptor (FR) targeting ligands, and linker-drug conjugates. The methods outlined in this patent aim to treat cancer effectively.

Career Highlights

Kai Ma is currently associated with Elucida Oncology, Inc., where he continues to advance his research in cancer treatment. His work is pivotal in developing new therapeutic strategies that leverage the unique properties of nanoparticles.

Collaborations

Some of his notable coworkers include Aranapakam Mudumbai Venkatesan and Feng Chen. Their collaborative efforts contribute to the innovative research environment at Elucida Oncology, Inc.

Conclusion

Kai Ma's contributions to the field of oncology through his patents and work at Elucida Oncology, Inc. highlight his commitment to advancing cancer treatment. His innovative approaches are paving the way for new therapeutic options in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…